Nicolas Chahine

Nicolas Chahine

InvestorPlace Contributor

About Nicolas Chahine

Recent Articles

Teladoc Stock Is Returning to Long-Term Pivotal Zones

By Nicolas Chahine, InvestorPlace Contributor

Demand for Teladoc services is will remain healthy far past the pandemic. Therefore, TDOC stock will find buyers in the long term.

Clover Health Desperately Needs Triage, but It Isn’t Doomed Yet

By Nicolas Chahine, InvestorPlace Contributor

Clover Health has a billion dollar yearly book of sales. Selloffs have limits, and we will soon find out if CLOV stock is a dud or a stud.

3 Biotech Stocks to Buy That Are Under Severe Pressure

By Nicolas Chahine, InvestorPlace Contributor

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.

The Cloudflare Stock Dip Is an Enticing Buying Opportunity

By Nicolas Chahine, InvestorPlace Contributor

Cloudflare positioned itself well for the long term. So NET stock 50% correction is an opportunity for new investors but not all in.

With Political Volatility, $140 Will Be a Key Point for Alibaba Stock

By Nicolas Chahine, InvestorPlace Contributor

BABA stock is inherently pretty risky, but there's reason to believe it could grow from here. $140 will be a crucial point in its ascent.

Load More